Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
BMC Medicine|December 6, 2016
Taking advantage of unexpected WebCONSORT resultsErik Cobo, José Antonio GonzálezMedicina Clinica|February 9, 2006
[Common and specific methodological features of checklists]Erik Cobo, Ruth Domínguez, Marta PulidoJournal of Clinical Epidemiology|June 19, 2007
Discordance between reported intention-to-treat and per protocol analysesNúria Porta, Catalina Bonet, Erik CoboMedicina Clinica|February 9, 2006
[Non-randomized evaluation studies (TREND)]Carles Vallvé, Maite Artés, Erik Cobo, et al.Statistics in Medicine|August 31, 2017
Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?Eduard Molins, Erik Cobo, Jordi OcañaBMJ Open|November 15, 2017
National citation patterns of <i>NEJM</i>, <i>The Lancet</i>, <i>JAMA</i> and <i>The BMJ</i> in the lay press: a quantitative content analysisGonzalo Casino, Roser Rius, Erik CoboTrials|January 31, 2018
Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers?David Blanco, Alice M Biggane, Erik Cobo, et al.Statistics in Medicine|December 8, 2004
Efficiency of the cross-over design: an empirical estimationRaquel Garcia, Marta Benet, Catalina Arnau, et al.Pharmaceutical Statistics|July 22, 2008
Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicolineKim Bolland, John Whitehead, Erik Cobo, et al.Biometrical Journal. Biometrische Zeitschrift|October 1, 2020
An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designsEduard Molins, Detlew Labes, Helmut Schütz, et al.Pageof 5